Klaushofer K - Search Results

1

Treatment Effects of Bisphosphonates and Denosumab on Survival and Refracture from Real-World Data of Hip-Fractured Patients.

Behanova M, Reichardt B, Stamm TA, Zwerina J, Klaushofer K, Kocijan R. Behanova M, et al. Among authors: klaushofer k. Calcif Tissue Int. 2019 Dec;105(6):630-641. doi: 10.1007/s00223-019-00611-3. Epub 2019 Sep 17. Calcif Tissue Int. 2019. PMID: 31531720

2

Mortality after hip fracture in Austria 2008-2011.

Brozek W, Reichardt B, Kimberger O, Zwerina J, Dimai HP, Kritsch D, Klaushofer K, Zwettler E. Brozek W, et al. Among authors: klaushofer k. Calcif Tissue Int. 2014 Sep;95(3):257-66. doi: 10.1007/s00223-014-9889-9. Epub 2014 Jul 3. Calcif Tissue Int. 2014. PMID: 24989776

3

Inflammatory Bowel Disease: A Nationwide Study of Hip Fracture and Mortality Risk After Hip Fracture.

Bartko J, Reichardt B, Kocijan R, Klaushofer K, Zwerina J, Behanova M. Bartko J, et al. Among authors: klaushofer k. J Crohns Colitis. 2020 Sep 16;14(9):1256-1263. doi: 10.1093/ecco-jcc/jjaa052. J Crohns Colitis. 2020. PMID: 32170313

4

The doubled burden of diabetic bone disease: hip fracture and post-hip fracture mortality.

Behanova M, Haschka J, Zwerina J, Wascher TC, Reichardt B, Klaushofer K, Kocijan R. Behanova M, et al. Among authors: klaushofer k. Eur J Endocrinol. 2021 May;184(5):627-636. doi: 10.1530/EJE-20-1155. Eur J Endocrinol. 2021. PMID: 33630752

5

Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study.

Brozek W, Reichardt B, Zwerina J, Dimai HP, Klaushofer K, Zwettler E. Brozek W, et al. Among authors: klaushofer k. Osteoporos Int. 2016 Jan;27(1):387-96. doi: 10.1007/s00198-015-3415-4. Epub 2015 Nov 17. Osteoporos Int. 2016. PMID: 26576544

6

Higher dose but not low dose proton pump inhibitors are associated with increased risk of subsequent hip fractures after first hip fracture: A nationwide observational cohort study.

Brozek W, Reichardt B, Zwerina J, Dimai HP, Klaushofer K, Zwettler E. Brozek W, et al. Among authors: klaushofer k. Bone Rep. 2019 Apr 1;10:100204. doi: 10.1016/j.bonr.2019.100204. eCollection 2019 Jun. Bone Rep. 2019. PMID: 30993153 Free PMC article.

7

Osteoporosis Therapeutics 2020.

Kocijan R, Klaushofer K, Misof BM. Kocijan R, et al. Among authors: klaushofer k. Handb Exp Pharmacol. 2020;262:397-422. doi: 10.1007/164_2020_373. Handb Exp Pharmacol. 2020. PMID: 32767142 Review.

8

Use of proton pump inhibitors and mortality after hip fracture in a nationwide study.

Brozek W, Reichardt B, Zwerina J, Dimai HP, Klaushofer K, Zwettler E. Brozek W, et al. Among authors: klaushofer k. Osteoporos Int. 2017 May;28(5):1587-1595. doi: 10.1007/s00198-017-3910-x. Epub 2017 Jan 12. Osteoporos Int. 2017. PMID: 28083667

9

Hypophosphatasia: From Diagnosis to Treatment.

Simon S, Resch H, Klaushofer K, Roschger P, Zwerina J, Kocijan R. Simon S, et al. Among authors: klaushofer k. Curr Rheumatol Rep. 2018 Sep 10;20(11):69. doi: 10.1007/s11926-018-0778-5. Curr Rheumatol Rep. 2018. PMID: 30203264 Review.

10

Low bone mineral density and fragility fractures in permanent vegetative state patients.

Oppl B, Michitsch G, Misof B, Kudlacek S, Donis J, Klaushofer K, Zwerina J, Zwettler E. Oppl B, et al. Among authors: klaushofer k. J Bone Miner Res. 2014;29(5):1096-100. doi: 10.1002/jbmr.2122. J Bone Miner Res. 2014. PMID: 24470043 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

361 results

Search Page

Filters